VKT Pharma
FDA Approved Drugs
VKT Pharma
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 15
- Latest Approval Date Dec 31, 2024
- Data Source FDA
- First Approval Date Jan 31, 2019
Company Overview
Social Profiles
Company Snapshot
VKT Pharma
Plot No: 72, H.No. 8-2-334/ 3 & 4, 4th Floor, Road No.05, Opp: SBI Executive Enclave, Banjara hills, Hyderabad – 500 034.
India
vktpharma.com/ info@vktpharma.com View on MapFDA Approved Drug Records ( 15 records )
Drug Name
FAMOTIDINE
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2022-01-07
Active Ingredient
FAMOTIDINE
Application Number
215630
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2022-01-07
Regulatory Status
RX
Drug Name
FAMOTIDINE
Product Number
2
Dosage Form
-
Strength
40MG
Approval Date
2022-01-07
Active Ingredient
FAMOTIDINE
Application Number
215630
Product Number
2
Dosage Form
-
Strength
40MG
Approval Date
2022-01-07
Regulatory Status
RX
Drug Name
FAMOTIDINE
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2022-01-28
Active Ingredient
FAMOTIDINE
Application Number
215822
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2022-01-28
Regulatory Status
OTC
Drug Name
FAMOTIDINE
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2022-01-28
Active Ingredient
FAMOTIDINE
Application Number
215822
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2022-01-28
Regulatory Status
OTC
Drug Name
RANITIDINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 150MG BASE
Approval Date
2019-01-31
Active Ingredient
RANITIDINE HYDROCHLORIDE
Application Number
211289
Product Number
1
Dosage Form
-
Strength
EQ 150MG BASE
Approval Date
2019-01-31
Regulatory Status
RX
Drug Name
RANITIDINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 300MG BASE
Approval Date
2019-01-31
Active Ingredient
RANITIDINE HYDROCHLORIDE
Application Number
211289
Product Number
2
Dosage Form
-
Strength
EQ 300MG BASE
Approval Date
2019-01-31
Regulatory Status
RX
Drug Name
RANOLAZINE
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2022-01-19
Active Ingredient
RANOLAZINE
Application Number
214035
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2022-01-19
Regulatory Status
RX
Drug Name
RANOLAZINE
Product Number
2
Dosage Form
-
Strength
1GM
Approval Date
2022-01-19
Active Ingredient
RANOLAZINE
Application Number
214035
Product Number
2
Dosage Form
-
Strength
1GM
Approval Date
2022-01-19
Regulatory Status
RX
Drug Name
SUMATRIPTAN SUCCINATE
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2024-12-31
Active Ingredient
SUMATRIPTAN SUCCINATE
Application Number
219036
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2024-12-31
Regulatory Status
RX
Drug Name
SUMATRIPTAN SUCCINATE
Product Number
2
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2024-12-31
Active Ingredient
SUMATRIPTAN SUCCINATE
Application Number
219036
Product Number
2
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2024-12-31
Regulatory Status
RX
Drug Name
SUMATRIPTAN SUCCINATE
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2024-12-31
Active Ingredient
SUMATRIPTAN SUCCINATE
Application Number
219036
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2024-12-31
Regulatory Status
RX
Drug Name
TADALAFIL
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2021-11-04
Active Ingredient
TADALAFIL
Application Number
215556
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2021-11-04
Regulatory Status
RX
Drug Name
TADALAFIL
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2021-11-04
Active Ingredient
TADALAFIL
Application Number
215556
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2021-11-04
Regulatory Status
RX
Drug Name
TADALAFIL
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2021-11-04
Active Ingredient
TADALAFIL
Application Number
215556
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2021-11-04
Regulatory Status
RX
Drug Name
TADALAFIL
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
2021-11-04
Active Ingredient
TADALAFIL
Application Number
215556
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
2021-11-04
Regulatory Status
RX
Related Databases
-
FDA Inspections
0 View
-
EDQM CEP
0 View
-
KDMF
0 View
-
Japan DMF
0 View
-
Eudra GMP
0 View
-
NDC Database
0 View
-
FDA Approved Drugs Database
15 View
-
Drug Prices in Switzerland
0 View
Drug Status Breakdown
15 total- RX
- OTC
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
FAMOTIDINE
Application Number
215630
Product Number
1
Active Ingredient
FAMOTIDINE
Dosage Form
-
Strength
20MG
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.